STAM2 activators target and enhance the activity of STAM2, a protein involved in intracellular signaling and trafficking. STAM2, or Signal Transducing Adaptor Molecule 2, plays a crucial role in the endosomal sorting complex required for transport (ESCRT) process, which is vital for the degradation and recycling of cell surface receptors and the termination of signaling cascades. The activators designed to enhance STAM2's function can influence various cellular pathways by stabilizing the protein or promoting its interaction with other ESCRT components. For example, a compound that increases the lipid-binding affinity of STAM2 could lead to a more efficient clustering of endosomal sorting complexes, thereby accelerating the trafficking of ubiquitinated proteins to lysosomes for degradation. Another activator might function by enhancing the ATPase activity associated with the ESCRT machinery, thus providing the necessary energy for the conformational changes required in the sorting process.
The specific biochemical mechanisms through which STAM2 activators exert their effects are diverse and intricate. Some activators may bind directly to the STAM2 VHS domain, which is responsible for recognizing ubiquitinated cargo, thus increasing the protein's cargo-selectivity and improving the fidelity of receptor trafficking. Other compounds might target the SH3 domain of STAM2, facilitating its interaction with proteins containing proline-rich motifs and promoting the assembly of the ESCRT complex. Additionally, activators could influence the post-translational modifications of STAM2, such as phosphorylation, which are essential for its functional activity within the cell. By enhancing the phosphorylation status of STAM2, these activators can promote its active conformation, leading to an upregulation of its role in the ESCRT pathway. The overall impact of STAM2 activators, therefore, lies in the fine-tuning of the protein's ability to engage in the cellular processes it regulates, ensuring that signaling pathways are terminated appropriately and cellular homeostasis is maintained.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can enhance the activity of STAM2 by promoting endosomal sorting required for multivesicular body (MVB) formation through the cAMP-dependent protein kinase A (PKA) pathway. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
8-Bromo-cAMP acts as a cAMP analog, enhancing the PKA pathway and potentially increasing the phosphorylation of proteins involved in the endocytic pathway, indirectly enhancing the function of STAM2. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin increases intracellular calcium levels, which could facilitate the calcineurin pathway affecting the trafficking and sorting of endocytic vesicles where STAM2 is involved. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC) which is involved in regulating intracellular trafficking, a process STAM2 is a key component of. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK, altering cellular responses and potentially enhancing the functionality of STAM2 by affecting the endocytic pathway. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $223.00 | 8 | |
Go6976 is a selective PKC inhibitor which, by modulating PKC activity, may enhance the trafficking and sorting function of STAM2. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A, as a protein phosphatase inhibitor, could enhance STAM2 function by increasing phosphorylation states of proteins involved in the endocytic pathway. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A disrupts the structure and function of the Golgi apparatus, which may indirectly enhance STAM2 activity by affecting intracellular trafficking pathways. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Monensin acts as an ionophore that alters intracellular pH and calcium levels, potentially modifying the sorting machinery and enhancing STAM2 function involved in endosomal trafficking. |